Chron's Disease is a chronic inflammatory intestinal disease, first described at the beginning of the last century. The disease is characterized by the alternation of periods of flares and remissions influenced by a complex pathogenesis in which inflammation plays a key role. Crohn's disease evolution is mediated by a complex alteration of the inflammatory response which is characterized by alterations of the innate immunity of the intestinal mucosa barrier together with a remodeling of the extracellular matrix through the expression of metalloproteins and increased adhesion molecules expression, such as MAcCAM-1. This reshaped microenvironment enhances leucocytes migration in the sites of inflammation, promoting a TH1 response, through the production of cytokines such as IL-12 and TNF-α. IL-12 itself and IL-23 have been targeted for the medical treatment of CD. Giving the limited success of medical therapies, the treatment of the disease is invariably surgical. This review will highlight the role of inflammation in CD and describe the surgical approaches for the prevention of the almost inevitable recurrence.

Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., et al. (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. BIOLOGY DIRECT, 15(1) [10.1186/s13062-020-00280-5].

Pathophysiology of Crohn’s disease inflammation and recurrence

Giuseppe Sica
2020

Abstract

Chron's Disease is a chronic inflammatory intestinal disease, first described at the beginning of the last century. The disease is characterized by the alternation of periods of flares and remissions influenced by a complex pathogenesis in which inflammation plays a key role. Crohn's disease evolution is mediated by a complex alteration of the inflammatory response which is characterized by alterations of the innate immunity of the intestinal mucosa barrier together with a remodeling of the extracellular matrix through the expression of metalloproteins and increased adhesion molecules expression, such as MAcCAM-1. This reshaped microenvironment enhances leucocytes migration in the sites of inflammation, promoting a TH1 response, through the production of cytokines such as IL-12 and TNF-α. IL-12 itself and IL-23 have been targeted for the medical treatment of CD. Giving the limited success of medical therapies, the treatment of the disease is invariably surgical. This review will highlight the role of inflammation in CD and describe the surgical approaches for the prevention of the almost inevitable recurrence.
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/18
English
Con Impact Factor ISI
Crohn’s disease; Crohn’s disease recurrence; Intestinal inflammatory diseases; Surgery
Petagna, L., Antonelli, A., Ganini, C., Bellato, V., Campanelli, M., Divizia, A., et al. (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. BIOLOGY DIRECT, 15(1) [10.1186/s13062-020-00280-5].
Petagna, L; Antonelli, A; Ganini, C; Bellato, V; Campanelli, M; Divizia, A; Efrati, C; Franceschilli, M; Guida, Am; Ingallinella, S; Montagnese, F; Sensi, B; Siragusa, L; Sica, G
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
13062_2020_Article_280.pdf

accesso aperto

Licenza: Non specificato
Dimensione 836.48 kB
Formato Adobe PDF
836.48 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/303237
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 14
  • ???jsp.display-item.citation.isi??? ND
social impact